IBDEI03C ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,1024,1,4,0)
 ;;=4^E27.40
 ;;^UTILITY(U,$J,358.3,1024,2)
 ;;=^5002742
 ;;^UTILITY(U,$J,358.3,1025,0)
 ;;=E29.1^^3^36^18
 ;;^UTILITY(U,$J,358.3,1025,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1025,1,3,0)
 ;;=3^Testicular hypofunction
 ;;^UTILITY(U,$J,358.3,1025,1,4,0)
 ;;=4^E29.1
 ;;^UTILITY(U,$J,358.3,1025,2)
 ;;=^5002754
 ;;^UTILITY(U,$J,358.3,1026,0)
 ;;=E53.8^^3^36^6
 ;;^UTILITY(U,$J,358.3,1026,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1026,1,3,0)
 ;;=3^Deficiency of other specified B group vitamins
 ;;^UTILITY(U,$J,358.3,1026,1,4,0)
 ;;=4^E53.8
 ;;^UTILITY(U,$J,358.3,1026,2)
 ;;=^5002797
 ;;^UTILITY(U,$J,358.3,1027,0)
 ;;=E78.0^^3^36^16
 ;;^UTILITY(U,$J,358.3,1027,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1027,1,3,0)
 ;;=3^Pure hypercholesterolemia
 ;;^UTILITY(U,$J,358.3,1027,1,4,0)
 ;;=4^E78.0
 ;;^UTILITY(U,$J,358.3,1027,2)
 ;;=^5002966
 ;;^UTILITY(U,$J,358.3,1028,0)
 ;;=E78.2^^3^36^12
 ;;^UTILITY(U,$J,358.3,1028,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1028,1,3,0)
 ;;=3^Mixed hyperlipidemia
 ;;^UTILITY(U,$J,358.3,1028,1,4,0)
 ;;=4^E78.2
 ;;^UTILITY(U,$J,358.3,1028,2)
 ;;=^78424
 ;;^UTILITY(U,$J,358.3,1029,0)
 ;;=E78.5^^3^36^8
 ;;^UTILITY(U,$J,358.3,1029,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1029,1,3,0)
 ;;=3^Hyperlipidemia, unspecified
 ;;^UTILITY(U,$J,358.3,1029,1,4,0)
 ;;=4^E78.5
 ;;^UTILITY(U,$J,358.3,1029,2)
 ;;=^5002969
 ;;^UTILITY(U,$J,358.3,1030,0)
 ;;=E86.9^^3^36^21
 ;;^UTILITY(U,$J,358.3,1030,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1030,1,3,0)
 ;;=3^Volume depletion, unspecified
 ;;^UTILITY(U,$J,358.3,1030,1,4,0)
 ;;=4^E86.9
 ;;^UTILITY(U,$J,358.3,1030,2)
 ;;=^332840
 ;;^UTILITY(U,$J,358.3,1031,0)
 ;;=E86.0^^3^36^7
 ;;^UTILITY(U,$J,358.3,1031,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1031,1,3,0)
 ;;=3^Dehydration
 ;;^UTILITY(U,$J,358.3,1031,1,4,0)
 ;;=4^E86.0
 ;;^UTILITY(U,$J,358.3,1031,2)
 ;;=^332743
 ;;^UTILITY(U,$J,358.3,1032,0)
 ;;=E87.6^^3^36^10
 ;;^UTILITY(U,$J,358.3,1032,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1032,1,3,0)
 ;;=3^Hypokalemia
 ;;^UTILITY(U,$J,358.3,1032,1,4,0)
 ;;=4^E87.6
 ;;^UTILITY(U,$J,358.3,1032,2)
 ;;=^60610
 ;;^UTILITY(U,$J,358.3,1033,0)
 ;;=E66.3^^3^36^13
 ;;^UTILITY(U,$J,358.3,1033,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1033,1,3,0)
 ;;=3^Overweight
 ;;^UTILITY(U,$J,358.3,1033,1,4,0)
 ;;=4^E66.3
 ;;^UTILITY(U,$J,358.3,1033,2)
 ;;=^5002830
 ;;^UTILITY(U,$J,358.3,1034,0)
 ;;=D64.9^^3^36^5
 ;;^UTILITY(U,$J,358.3,1034,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1034,1,3,0)
 ;;=3^Anemia, unspecified
 ;;^UTILITY(U,$J,358.3,1034,1,4,0)
 ;;=4^D64.9
 ;;^UTILITY(U,$J,358.3,1034,2)
 ;;=^5002351
 ;;^UTILITY(U,$J,358.3,1035,0)
 ;;=M81.0^^3^36^4
 ;;^UTILITY(U,$J,358.3,1035,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1035,1,3,0)
 ;;=3^Age-related osteoporosis w/o current pathological fracture
 ;;^UTILITY(U,$J,358.3,1035,1,4,0)
 ;;=4^M81.0
 ;;^UTILITY(U,$J,358.3,1035,2)
 ;;=^5013555
 ;;^UTILITY(U,$J,358.3,1036,0)
 ;;=R73.09^^3^36^1
 ;;^UTILITY(U,$J,358.3,1036,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1036,1,3,0)
 ;;=3^Abnormal Glucose NEC
 ;;^UTILITY(U,$J,358.3,1036,1,4,0)
 ;;=4^R73.09
 ;;^UTILITY(U,$J,358.3,1036,2)
 ;;=^5019563
 ;;^UTILITY(U,$J,358.3,1037,0)
 ;;=B96.81^^3^37^58
 ;;^UTILITY(U,$J,358.3,1037,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1037,1,3,0)
 ;;=3^Helicobacter pylori as the cause of diseases classd elswhr
 ;;^UTILITY(U,$J,358.3,1037,1,4,0)
 ;;=4^B96.81
 ;;^UTILITY(U,$J,358.3,1037,2)
 ;;=^5000857
 ;;^UTILITY(U,$J,358.3,1038,0)
 ;;=B15.9^^3^37^62
 ;;^UTILITY(U,$J,358.3,1038,1,0)
 ;;=^358.31IA^4^2
 ;;
 ;;$END ROU IBDEI03C
